This multicentre, randomized controlled trial evaluates the effect and safety of acupuncture combing with PD-1 inhibitors plus chemotherapy in NSCLC. Participants will be randomly assigned to undergo either acupuncture or sham acupuncture concurrent with the initial four-six cycles of chemotherapy combined with PD-1 inhibitors.
Phase:
NA
Details
Lead Sponsor:
Guangzhou University of Traditional Chinese Medicine
Collaborators:
Jiangsu Province Hospital of Traditional Chinese Medicine The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine